Hikma Pharmaceuticals USA Inc. Recall: Ativan Injection (lorazepam injection, USP), 2mg/mL
Hikma Pharmaceuticals USA Inc. Recall: Ativan Injection (lorazepam injection, USP), 2mg/mL is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Hikma Pharmaceuticals USA Inc.; Product: Ativan Injection (lorazepam injection, USP), 2mg/mL, 1 mL vial, 25 vials per carton, RX Only, Manufactured
| Recalling firm | Hikma Pharmaceuticals USA Inc. |
|---|---|
| Product | Ativan Injection (lorazepam injection, USP), 2mg/mL, 1 mL vial, 25 vials per carton, RX Only, Manufactured by West-Ward Eatontown, NJ 07724, Carton NDC# 0641-6001-25, Vial NDC# 0641-6001-01 |
| Reason for recall | Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples. |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | Nationwide in the USA |
| Recall initiated | 20220711 |
| Recall number | D-1308-2022 |
| Category | drug |
| State | NJ |
| Country | United States |
$29/mo
Try RecallGuard →